 |
|
|
|
| Selected Reading |
 Abdullah ASM, Tomlinson B, Cockram CS, et al. Lessons from the severe acute respiratory syndrome outbreak in Hong Kong. Emerg Infect Dis 2003 Sep;9(9):1042-5 [Full text]
Ahuja AT, Wong JKT. Radiological appearances of recent cases of atypical pneumonia in Hong Kong. On Web site of Chinese University of Hong Kong, Dept of Diagnostic Radiology & Organ Imaging
[Full text]
Anand K, Ziebuhr J, Wadhwani P, et al. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drug. Science 2003 May 13 (early online publication) [Abstract]
Antia R, Regoes RR, Koella JC, et al. The role of evolution in the emergence of infectious diseases. (Letter) Nature 2003 Dec 10;426(6967):658-61 [Abstract]
Arguin PM, Navin AW, Steele SF, et al. Health communication during SARS. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Bassetti S, Bischoff WE, Sherertz RJ. Are SARS superspreaders cloud adults? (Letter) Emerg Infect Dis 2005 Apr;11(4):637-8 [Full text]
Bell DM, and WHO Working Group on Prevention of International and Community Transmission of SARS. Public health interventions and SARS spread, 2003. Emerg Infect Dis 2004 Nov;10(11):1900-6 [Full text]
Bell DM, for World Health Organization Working Group on Prevention of International and Community Transmission of SARS. Public health interventions and SARS spread, 2003. Emerg Infect Dis 2004 Nov;10(11) [Full text]
Bergeron SL, Sanchez AL. Media effects on students during SARS outbreak. Emerg Infect Dis 2005 May;11(5) [Full text]
Bisht H, Roberts A, Vogel L, et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci 2004 Apr 27;101(17):6641-6 [Abstract]
Bitnun A, Allen U, Heurter H, et al. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics 2003 Oct;112:e261 [Abstract]
Bitnun A, Read S, Tellier R, et al. Severe acute respiratory syndrome-associated coronavirus infection in Toronto children: a second look. Pediatrics 2009 Jan;123(1):97-101 [Abstract]
Blendon RJ, Benson JM, DesRoches CM, et al. The public's response to severe acute respiratory syndrome in Toronto and the United States. Clin Infect Dis 2004 Apr 1;38(7):925-31 [Abstract]
Bloom BR. Lessons from SARS. (Editorial) Science 2003 May 2;300:701 [Full text]
Booth TF, Kournikakis B, Bastien N, et al. Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis 2005 May 1;191(9):1472-7 [Abstract - See also Tong below]
Breiman RF, Evans MR, Preiser W, et al. Role of China in the quest to define and control severe acute respiratory syndrome. Emerg Infect Dis 2003 Sep;9(9):1037-41 [Full text]
Breugelmans JG, Zucs P, Porten K, et al. SARS transmission and commercial aircraft. (Letter) Emerg Infect Dis 2004 Aug;10(8) (published ahead of print) [Full text]
Breugelmans JG, Zucs P, Porten K. SARS transmission and commerical aircraft. (Letter) Emerg Infect Dis 2004 Aug;10(8):1502-3 [Full text]
Brown EG, Tetro JA. Comparative analysis of the SARS coronavirus genome: a good start to a long journey. (Commentary) Lancet 2003 May 24;361(9371):1756-7 [Abstract]
Buchholz UJ, Bukreyev A, Yang L, et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci 2004 Jun 29;101(26):9804-9 [Full text]
Bukreyev A, Lamirande EW, Buchholz UJ, et al. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 2004 Jun 26;363(9427):2122-7 [Abstract]
Bull K, Dykhuizen D. Virus evolution: epidemics-in-waiting. (Editorial) Nature 2003 Dec 10;426(6967):609-10
Cameron MJ, Ran L, Xu L, et al. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 2007 Aug;81(16):8692-707 [Abstract]
Cameron PA. The plague within: an Australian doctor's experience of SARS in Hong Kong. (Personal Perspective) Med J Aust 2003 May 19;178(10):512-3 [Abstract]
Camitz M, Liljeros F. The effect of travel restrictions on the spread of a moderately contagious disease. BMC Med 2006;4(32) (published online Dec 14) [Abstract]
Cao WC, Zhang PH, Richardus JH. Disappearance of antibodies to SARS-associated coronavirus after recovery. (Letter) N Engl J Med 2007 Sep 13;357(11):1162-3 [Full text]
Cauchemez S, Boelle PY, Donnelly CA, et al. Real-time estimates in early detection of SARS. Emerg Infect Dis 2005 Jan;12(1) [Full text]
CDC. Air medical transport for SARS patients. Interim guidance. Apr 23, 2004 [Full text]
CDC. Clinical guidance on the identification and evaluation of possible SARS-CoV disease among persons presenting with community-acquired illness. Originally published Dec 3, 2003. Updated Jan 8, 2004 [Full text]
CDC. Cluster of severe acute respiratory syndrome cases among protected health-care workers: Toronto, Canada, April 2003. MMWR 2003 May 16;52(19):433-6 [Full text]
CDC. Efficiency of quarantine during an epidemic of severe acute respiratory syndrome: Beijing, China, 2003. MMWR 2003 Oct 31;52(43):1037-40 [Full text]
CDC. Fact sheet for SARS patients and their close contacts. Feb 6, 2004 [Web page]
CDC. Fact Sheet: Basic information about SARS [Full text]
CDC. Guidance about SARS for airline flight crews, cargo and cleaning personnel, and personnel interacting with arriving passengers. Apr 23, 2004 [Full text]
CDC. Guidance about SARS for Americans living abroad. Feb 11, 2004 [Web page]
CDC. Guidance about SARS for persons traveling to areas where SARS cases have been reported. Feb 11, 2004 [Web page]
CDC. Guidance for SARS preparedness for infection control. Sep 29, 2003 [Full text]
CDC. Guidance for surveillance and early detection of SARS. Sep 11, 2003 [Full text]
CDC. Guidelines for collection of specimens from potential cases of SARS. Dec 4, 2003 [Full text]
CDC. Guidelines for laboratory diagnosis of SARS-CoV infection. Dec 10, 2003 [Full text]
CDC. In the absence of SARS-CoV transmission worldwide: guidance for surveillance, clinical and laboratory evaluation, and reporting. Published Dec 3, 2003; updated Jan 21, 2004 [Full text]
CDC. Inclusion of official counts of SARS-CoV disease in National Notifiable Diseases Surveillance System data presentation. MMWR 2003 Dec 12;52(49):1210 [Full text]
CDC. Interim guidance for institutions or organizations hosting persons arriving in the United States from areas with SARS. May 14, 2003 [Full text]
CDC. Letter to health-care providers. Jun 18, 2003 [Full text]
CDC. Outbreak notice: respiratory illness in Long-term care facility in British Columbia, Canada: Aug 14, 2003 [Full text]
CDC. Outbreak of severe acute respiratory syndrome: worldwide, 2003. MMWR 2003 Apr 4;52(13):269-72 [Full text]
CDC. Outbreak of severe acute respiratory syndrome: worldwide, 2003. MMWR 2003 Mar 21;51(11):226-8 [Full text]
CDC. Outbreak of severe acute respiratory syndrome: worldwide, 2003. MMWR 2003 Mar 28;55(RR-6):241-8 [Full text]
CDC. Preliminary clinical description of severe acute respiratory syndrome. MMWR 2003 Mar 28;52(12):255-6 [Full text]
CDC. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003. MMWR 2003 Oct 17;52(41):986-7 [Full text]
CDC. Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). Jan 8, 2004 [Full text]
CDC. Revised US surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases: United States and worldwide, December 2003. MMWR 2003 Dec 12;52(49):1202-6 [Full text]
CDC. SARS coronavirus infection in Singapore patient. Updated Sep 18, 2003 [Web page]
CDC. SARS, influenza, and use of influenza vaccine. MMWR 2003 Oct 3;52(39):941-2 [Full text]
CDC. Severe acute respiratory syndrome (SARS) and coronavirus testing: United States, 2003. MMWR 2003 Apr 11;52(14):297-302 [Full text]
CDC. Severe acute respiratory syndrome: Singapore, 2003. MMWR 2003 May 9;52(18):405-11 [Full text]
CDC. Severe acute respiratory syndrome: Taiwan, 2003. CDC. MMWR 2003 May 23;52(20):461-6 [Full text]
CDC. Severe acute respiratory syndrome: Toronto, Canada, 2003. MMWR Jun 13;52(23):547-50 [Full text]
CDC. Severe acute respiratory syndrome: United States, 2003. MMWR 2003 Apr 18;52(15):332-6 [Full text]
CDC. Severe acute respiratory syndrome: United States, 2003. MMWR 2003 Apr 25;52(16):357-60 [Full text]
CDC. Severe acute respiratory syndrome: United States, 2003. MMWR 2003 Jul 4;52(26):616 [Full text]
CDC. Severe acute respiratory syndrome: United States, 2003. MMWR 2003 Jun 6;52(22):525-6 [Full text]
CDC. Severe acute respiratory syndrome: United States, 2003. MMWR 2003 May 2;52(17):388-90 [Full text]
CDC. Severe acute respiratory syndrome: United States, 2003. MMWR 2003 May 9;52(18):411-3 [Full text]
CDC. Severe acute respiratory syndrome: United States, June 11, 2003. MMWR 2003 Jun 13;52(23):550 [Full text]
CDC. Severe acute respiratory syndrome: United States, June 18, 2003. MMWR 2003 Jun 20;52(24):570 [Full text]
CDC. Severe acute respiratory syndrome: United States, May 14, 2003. MMWR 2003 May 16;52(19):436-8 [Full text]
CDC. Severe acute respiratory syndrome: United States, May 21, 2003. MMWR May 23;52(20):466-8 [Full text]
CDC. Severe acute respiratory syndrome: United States, May 28, 2003. MMWR 2003 May 30;52(21):500-1 [Full text]
CDC. Severe acute respiratory syndrome: worldwide and United States, 2003. MMWR Jul 18;52(28):664-5 [Full text]
CDC. Updated interim domestic infection control guidance in the health care and community setting for patients with suspected SARS. May 1, 2003 [Full text]
CDC. Updated interim surveillance case definition for severe acute respiratory syndrome (SARS): United States, April 29, 2003. MMWR 2003 Apr 29;52(17):1-3 [Full text]
CDC. Updated interim U.S. case definition of SARS. July 18, 2003 [Full text]
CDC. Use of quarantine to prevent transmission of SARS: Taiwan, 2003. MMWR 2003 Jul 25;52(29):680-3 [Full text]
Chan KH, Poon LL, Cheng VCC, et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Chan KH, Sonnenberg K, Niedrig M, et al. Use of antibody avidity assays for diagnosis of severe acute respiratory syndrome coronavirus infection. Clin Vaccine Immunol 2007 Nov;14(11):1433-6 [Abstract]
Chan LY, Lee N, Chan PKS, et al. Diagnostic criteria during SARS outbreak in Hong Kong. (Letter) Emerg Infect Dis 2004 Jun;10(6):1168-70 [Full text]
Chan PK, Lim PL, Liu EY, et al. Antibody avidity maturation during severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis 2005 Jul 1;192(1):166-9 [Abstract]
Chan PKS, Ip M, Ng KC, et al. Severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis 2003 Nov;9(11):1453-4 [Full text]
Chan PKS, Tam JS, Lam C-W, et al. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003 Sep;9(9):1058-63 [Full text]
Chan PKS, To W-K, Ng K-C, et al. Laboratory diagnosis of SARS. Emerg Infect Dis 2004 May;10(5) [Full text]
Chang W-T, Kao C-L, Chung M-Y, et al. SARS exposure and emergency department workers. Emerg Infect Dis 2004 Jun;10(6):1117-9 (Published ahead of print) [Full text]
Che XY, Hao W, Wang Y, et al. Nucleocapsid protein as early diagnostic marker for SARS. Emerg Infect Dis 2004 Nov;10(11):1947-9 [Full text]
Chen L, Gui C, Luo X, et al. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 2005 June 1;79(11):7095-103 [Abstract]
Chen L, Liu P, Gao H, et al. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clin Infect Dis 2004 Nov 15;39(10):1531-5 [Abstract]
Chen NH, Wang PC, Hsieh MJ, et al. Impact of severe acute respiratory syndrome care on the general health status of healthcare workers in Taiwan. Infect Control Hosp Epidemiol 2007 Jan;28(1):75-9 [Abstract]
Chen W, Yan M, Yang L, et al. SARS-associated coronavirus transmitted from human to pig. Emerg Infect Dis 2005 Mar;11(3):446-8 [Full text]
Chen WJ, Yang JY, Lin JH, et al. Nasopharyngeal shedding of severe acute respiratory syndrome?associated coronavirus is associated with genetic polymorphisms. Clin Infect Dis 2006 Jun 1;42(11):1561-9 [http://dx.doi.org/10.1086/503843]
Chen WK, Wu HD, Lin CC, et al. Emergency department response to SARS, Taiwan. Emerg Infect Dis 2005 Jul;11(7):1067-73 [Full text]
Chen WQ, Lu CY, Wong TW, et al. Anti-SARS-CoV immunoglobulin G in healthcare workers. Emerg Infect Dis 2005 Jan;11(1):89-94 [Full text]
Chen X, Zhou B, Li Meizhong L, et al. Serology of severe acute respiratory syndrome: implications for surveillance and outcome. J Infect Dis 2004 Apr 1;189(7):1158-63 [Abstract]
Chen XP, Cao Y. Consideration of highly active antiretroviral therapy in the prevention and treatment of severe acute respiratory syndrome. Clin Infect Dis 2004 Apr 1;38(7):1030-2 [Abstract]
Chen Y-C, Chen P-J, Chang S-C, et al. Infection control and SARS transmission among healthcare workers, Taiwan. Emerg Infect Dis 2004 May;10(5) [Full text]
Chen Y-C, Huang L-M, Chan C-C, et al. SARS in hospital emergency room. Emerg Infect Dis 2004 May;10(5) [Full text]
Chen YM, Liang SY, Shih Yp, et al. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol 2006 Feb;4492):359-65 [Abstract]
Cheng VCC, Hung IFN, Tang BSF, et al. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin Infect Dis 2004 Feb 15;38(4):467-75 [Abstract]
Cheng VCC, Lau SKP, Woo PCY, et al. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007 Oct;20(4):660-94 [Abstract]
Cheung CY, Poon LL, Ng IH, et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macorphages in vitro: possible relevance to pathogenesis. J Virol 2005 Jun;79(12):7819-26 [Abstract]
Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004 Mar 12;303(5664):1666-9 [Abstract]
Chiu SS, Chan KH, Chu KW, et al. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis 2005 Jun 15;40(12):1721-9 [Abstract]
Chow PKJ, Ooi E-E, Tan H-K, et al. Healthcare worker seroconversion in SARS outbreak. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Chowell G, Castillo-Chavez C, Fenimore PW, et al. Model parameters and outbreak control for SARS. Emerg Infect Dis 2004 Jul;10(7):1258-63 [Full text]
Christian MD, Loutfy M, McDonal LC, et al. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Christian MD, Poutanen SM, Loutify MR, et al. Severe acute respiratory syndrome. Clin Infect Dis 2004 May 15;38(10):1420-7 [Abstract]
Chu CM, Cheng VC, Hung IF, et al. Viral load distribution in SARS outbreak. Emerg Infect Dis 2005 Dec;11(12):1882-6 [Full text]
Chu CM, Cheng VCC, Hung IFN, et al. Viral load distribution in SARS outbreak. Emerg Infect Dis 2005 Dec;11(12) [Full text]
Colizza V, Barrat A, Barthelemy M, et al. Predictability and epidemic pathways in global outbreaks of infectious diseases: the SARS case study. BMC Med 2007;5:34 (published online Nov 21) [Abstract]
Cowling BJ, Muller MP, Wong IO, et al. Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings. Arch Intern Med 2006 Jul 24;155(14):1505-11 [Abstract]
Darnell MER, Plant EP, Watanabe H, et al. Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets. J Infect Dis 2007 Nov 1;196(9):1329-38 [Abstract]
de Lang A, Baas T, Teal T, et al. Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. PLoS Pathog 2007 Aug;3(8):e112 [Full text]
Derrick JL, Gomersall CD. Surgical helmets and SARS infection. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Des Jarlais DC, Stuber J, Tracy M, et al. Social factors associated with AIDS and SARS. Emerg Infect Dis 2005 Nov;11(11):1767-9 [Full text]
Desenclos J-C, Van der Werf S, Bonmarin I, et al. Introduction of SARS in France, March-April, 2003. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Dimoulas P, Green KA, Shigayeva A, et al. Patient contact recall after SARS exposure. Emerg Infect Dis 2005 Apr;11(4):625-8 [Full text]
Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004 Jun;203(2):622-30 [Abstract]
Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003 May 24;361(9371):1761-6 [Abstract]
Dowell SF, Simmerman JM, Erdman DD, et al. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clin Infect Dis 2004 Sep 1;39(5):652-7 [Abstract]
Drazen JM. Case clusters of the severe acute respiratory syndrome. (Editorial) N Engl J Med 2003 May 15;348(20):e6-7 [Full text]
Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003 May 15;348(20):1967-76 [Full text]
Emery SL, Erdman DD, Bowen MD, et al. Real-time reverse transciption-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Enserink M. SARS: a pandemic prevented. (Breakthrough of the year) Science 2003 Dec 19;302(5653):2045 [Abstract]
Esswein EJ, Kiefer M, Wallingford K, et al. Environmental and occupational health response to SARS, Taiwan, 2003. Emerg Infect Dis 2004 Jul;10(7):1187-94 [Full text]
Falsey AR, Walsh EE. Novel coronavirus and severe acute respiratory syndrome. (Commentary) Lancet 2003 Apr 19;361(9366):1312-3 [Full text]
Farcas GA, Poutanen SM, Mazzulli T, et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis 2005 Jan 15;191(2):193-7 [Abstract]
FDA. FDA issues guidance on severe acute respiratory syndrome to further safeguard the blood supply. FDA Talk Paper. Apr 17, 2003 [Full text]
Fedson DS. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. (Editorial Commentary) Clin Infect Dis 2003 Jun 15;36(12):1562-3 [Full text]
Fouchier RA, Hartwig NG, Bestegroer TM, et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci 2004 Apr 20;101(16):6212-6 [Abstract]
Fraser C, Riley S, Anderson RM, et al. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci 2004 Apr 20;101(16):6146-51 [Abstract]
Fung CP, Hsieh TL, Tan KH, et al. Rapid creation of a temporary isolation ward for patients with severe acute respiratory syndrome in Taiwan. Infect Control Hosp Epidemiol 2004 Dec;25(12):1026-32 [Abstract]
Galvani AP, Lei X, Jewell NP. Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times. Emerg Infect Dis 2003 Aug;9(8):991-4 [Full text]
Gamage B, Moore D, Copes R, et al. Protecting health care workers from SARS and other respiratory pathogens: A review of the infection control literature. Am J Infect Control 2005 Mar;22(2) [Abstract]
GAO (General Accounting Office). SARS: established infectious disease control measures helped contain spread, but a large-scale resurgence may pose challenges. Statement of Marjorie Kanof before Senate Permanent Subcommittee on Investigation, Committee on Governmental Affairs. GAO-03-105 [Full text]
Gao W, Tamin A, Soloff A, et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 2003 Dec 6;362(9399):1895-6 [Abstract]
Gerberding JL. Faster . . . but fast enough? Responding to the epidemic of severe acute respiratory syndrome. (Editorial) N Engl J Med 2003 May 15;348(20):2030-1 [Full text]
Goh DL-M, Lee BW, Chia KS, et al. Secondary household transmission of SARS, Singapore. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Goldsmith CS, Tatti KM, Ksiazek TG, et al. Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Gopolakrishna G, Choo P, Leo YS, et al. SARS transmission and hospital containment. Emerg Infect Dis 2004 Mar;10(3):395-400 [Full text]
Gorbalenya AE, Snijder EJ, Spaan WJM. Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J Virol 2004 Aug;78(15):7863-6 [Full text]
Groneberg DA, Poutanen SM, Low DE, et al. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis 2005 Mar;5(3):147-55 [Abstract]
Groneberg DA, Poutanen SM, Low DE, et al. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis 2005 Mar;5(3):147-55 [Abstract]
Guan Y, Zheng YQ, He XL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science 2003 (Published online Sep 4) [Abstract]
Ha LD, Bloom SA, Hien NQ, et al. Lack of SARS transmission among public hospital workers, Vietnam. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Haagmans BL, Kuiken T, Martina BE, et al. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 2004 Mar;10(3):290-3 [Abstract]
Haagmans BL, Osterhaus AD. Nonhuman primate models for SARS. (Perspective) PLoS Med 2006 May;3(5) [Full text]
Hamburg MA. SARS threat preparedness. Testimony before Government Reform Committee, US House of Representatives, 108th Congress. Apr 9, 2003 [Full text]
Hawryluck L, Gold WL, Robinson S, et al. SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis 2004 Jul;10(7):1206-12 [Full text]
Hensley LE, Fritz E, Jahrling PB, et al. Interferon-beta 1a and SARS coronavirus replication. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Heymann DL, Rodier G. Global surveillance, national surveillance, and SARS. (Commentary) Emerg Infect Dis 2004 Feb;10(2) [Full text]
Ho AS, Sung JJY, Chan-Yeung M. An outbreak of severe acute respiratory syndrome among hospital workers in a community hospital in Hong Kong. Ann Intern Med 2003 Oct 7;139(7):564-7 [Abstract]
Ho KY, Singh K, Habib A, et al. Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore. J Infect Dis 2004 Feb 15;189(4):642-7 [Abstract]
Ho MS, Chen WJ, Chen HY, et al. Neutralizing antibody response and SARS severity. Emerg Infect Dis 2005 Nov;11(11):1730-7 [Full text]
Ho W. Guideline on management of severe acute respiratory syndrome (SARS). (Commentary) Lancet 2003 Apr 19;361(9366):1313-5 [Abstract]
Holms KV. SARS-associated coronavirus. (Perspective) N Engl J Med 2003 May 15;348(20):1948-51 [Full text]
Hon KLE, Leung CW, Cheng WTF, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. (Research Letter) Lancet 2003 May 17;361(9370):1701-2 [Abstract]
Hopkins RS, Misegades L, Ransom J, et al. SARS preparedness checklist for state and local health officials. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Hourfar MK, Roth WK, Seifried E, et al. Comparison of two real-time quantitative assays for detection of SARS coronavirus. J Clin Microbiol 2004 May;42(5):2094-100 [Abstract]
Hsieh Y-H, Chen CWS, Jsu S-B. SARS outbreak, Taiwan, 2003. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Hsieh YH, King CC, Chen CWS, et al. Quarantine for SARS, Taiwan. Emerg Infect Dis 2005 Feb;11(2) [Full text]
Hsieh YH, Lee JY, Chang HL. SARS epidemiology modeling. (Letter) Emerg Infect Dis 2004 Jun;10(6):1165-8 [Full text]
Hsu L-Y, Lee C-C, Green JA, et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003 Jun;9(6):713-7 [Full text]
Hsueh P-R, Chen P-J, Hsiao C-H, et al. Patient data, early SARS epidemic, Taiwan. Emerg Infect Dis 2004 Mar;10(3):489-93 [Full text]
Hsueh P-R, Hsiao C-H, Yeh S-H, et al. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003 Sep;9(9):1063-7 [Full text]
Hsueh PR, Kao CL, Lee CN, et al. SARS antibody test for serosurveillance. Emerg Infect Dis 2004 Sep;10(9):1558-62 [Full text]
Huang Y, Yang Z-Y, Kong W-P, et al. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production. J Virol 2004 Nov;78(22):12557-65 [Abstract]
Hughes JM. The impressive and rapidly expanding knowledge base on SARS. (Commentary) Emerg Infect Dis 2004 Feb;10(2) [Full text]
Hui RKH, Zeng F, Chan CMN, et al. Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome. J Clin Microbiol 2004 May;42(5):1994-9 [Abstract]
Hung IFN, Cheng VCC, Wu AKL, et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 2004 Sep;10(9):1550-7 [Full text]
Imai T, Takahashi K, Hoshuyama T, et al. SARS risk perceptions in healthcare workers, Japan. Emerg Infect Dis 2005 Mar;11(3):404-10 [Full text]
Institute for Bioethics, Health Policy and Law, University of Louisville School of Medicine. Quarantine and isolation: lessons learned from SARS. Nov 2003 [Full text]
IOM (Institute of Medicine). Learning from SARS: preparing for the next disease outbreak. Summary of Sep 30-Oct 1, 2003, Forum on Microbial Threats workshop. Prepublication version. Washington, DC: National Academies Press, 2004 [Full text]
IOM (Institute of Medicine). Microbial threats to health: emergence, detection, and response. Mar 18, 2003 [Full text]
Ip M, Chan PKS, Lee N, et al. Seroprevalence of antibody to severe acute respiratory syndrome (SARS)-associated coronavirus among health care workers in SARS and non-SARS medical wards. Clin Infect Dis 2004 Jun 15;38(12):e116-8 [Abstract]
Ip WK, Chan KH, Law HK, et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005 May 15;191(10):1697-704 [Abstract]
Isakbaeva ET, Khetsuriani N, Beard RS, et al SARS-associated coronavirus transmission, United States. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Jefferson T, Foxlee R, Del Mar C, et al. Interventions for the interruption or reduction of the spread of respiratory viruses. Cochrane Database Syst Rev 2007 Oct 17;(4):CD006207 [Abstract]
Jernigan JA, Low DE, Helfand RF. Combining clinical and epidemiologic features for early recognition of SARS. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Jiang S, He Y, Liu S. SARS vaccine development. Emerg Infect Dis 2005 Jul;11(7):1016-20 [Full text]
Jiang SS, Chen TC, Yang JY, et al. Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction. Clin Infect Dis 2004 Jan 15;38(2):293-6 [Abstract]
Johnston RE. A candidate vaccine for severe acute respiratory syndrome. N Engl J Med 2004 Aug 19;351(8):827-8 [Extract]
Jones KE, Patel NG, Levy MA, et al. Global trends in emerging infectious diseases. Nature 2008 Feb 21;451(7181):990-3 [Abstract]
Joyntand GM, Yap HY. SARS in the intensive care unit. Curr Infect Dis Rep 2004 Jun;6(3):228-33 [Abstract]
Karesh WB, cook RA, Gilbert M, et al. Implications of wildlife trade on the movement of avian influenza and other infectious diseases. J Wildl Dis 2007 Jul;43(3 suppl):S55-9 [Abstract]
Kaydos-Daniels SC, Olowokure B, Chang H-J, et al. Body temperature monitoring and SARS fever hotline, Taiwan. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Kaye M, Druce J, Tran T, et al. SARS-associated coronavirus replication in cell lines. Emerg Infect Dis 2005 Jan;12(1) [Full text]
Kim TW, Lee JH, Hung C-F, et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 2004 May;78(9):4638-45 [Abstract]
Knowles SR, Phillips EJ, Dresser L, et al. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. 2003 Oct 15;37(8):1139-42 [Abstract]
Koh D, Takahashi K, Lim MK, et al. SARS risk perception and preventive measures, Singapore and Japan. (Letter) Emerg Infect Dis 2005 Apr;11(4):641-2 [Full text]
Ksiazek TG, Erdman D, Goldsmith C, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003 May 15 (early online release Apr 10) [Full text]
Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005 Aug;11(8):875-9 [Abstract]
La Montagne JR, Simonsen L, Taylor RJ, et al. Severe acute respiratory syndrome: developing a research response. J Infect Dis 2004 Feb 15;189(4):634-41 [Abstract]
Lai KN, Tsang KW, Seto WH, et al. Clinical, laboratory, and radiological manifestation of SARS. Curr Infect Dis Rep 2004 Jun;6(3):213-9 [Abstract]
Lai MYY, Cheng PKC, Lim WWL. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis 2005 Oct 1;41(7):e67-71 [Abstract]
Lan YC, Liu TT, Yang JY, et al. Molecular epidemiology of severe acute respiratory syndrome-associated coronavirus infections in Taiwan. J Infect Dis 2005 May 1;191(9):1478-89 [Abstract]
Lau JT, Tsui J, Lau M, et al. SARS transmission, risk factors, and prevention, Hong Kong. Emerg Infect Dis 2004 Apr;10(4):587-92 [Full text]
Lau JTF, Fung KS, Wong TW, et al. SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Lau JTF, Lau M, Kim JH, et al. Probable secondary infections in households of SARS patients in Hong Kong. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Lau JTF, Yang X, Leung PC, et al. SARS in three categories of hospital workers, Hong Kong. Emerg Infect Dis 2004 Aug;10(8) (published ahead of print) [Full text]
Lau JTF, Yang X, Leung PC, et al. SARS in three categories of hospital workers, Hong Kong. Emerg Infect Dis 2004 Aug;10(8):1399-404 [Full text]
Lau JTF, Yang X, Pang E, et al. SARS-related perceptions in Hong Kong. Emerg Infect Dis 2005 Mar;11(3):417-24 [Full text]
Lau K-K, Yu W-C, Chu D-M, et al. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Lau SK, Woo PC, Li KS, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci 2005 Sep 27;102(39):14040-5 [Abstract]
Lau SK, Woo PC, Wong BH, et al. Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in SARS patients by enzyme-linked immunosorbent assay. J Clin Microbiol 2004 Jul;42(7):2884-9 [Abstract]
Lawler JV, Endy TP, Hensley LE, et al. Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med 2006 May;3(5) [Full text]
Lee DT, Wing YK, Leung HC, et al. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin Infect Dis 2004 Oct 15;39(8):1247-9 [Abstract]
Lee HKK. Asymptomatic severe acute respiratory syndrome-associated coronavirus infection. (Letter) Emerg Infect Dis 2003 Nov;9(11):1491-2 [Full text]
Lee N, Hui D, Wu A. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003 May 15;348(20):1986-94 [Full text]
Lee N, Sung JJ. Nosocomial transmission of SARS. Curr Infect Dis Rep 2003 Dec;5(6):473-6 [Abstract]
Leong HN, Chan KP, Khan AS, et al. Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital. Emerg Infect Dis 2004 Oct;10(10):1745-50 [Full text]
Leung GM, Chung PH, Tsang T, et al. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis 2004 Sep;10(9):1653-6 [Full text]
Leung GM, Ho LM, Chan SKK, et al. Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong. Clin Infect Dis 2005 Jun 15;40(12):1713-20 [Abstract]
Leung GM, Quah S, Ho LM, et al. A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic. Infect Control Hosp Epidemiol 2004 Dec;25(12):1033-41 [Abstract]
Leung GM, Rainer TH, Lau FL, et al. A clinical prediction rule for diagnosing severe acute respiratory syndrome in the emergency department. Ann Intern Med 2004 Sep 7;141(5):333-42 [Abstract]
Li B-j, Tang Q, Cheng D, et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nature 2005 Sep;11:907-1011 [Abstract]
Li L, Gu J, Shi X, et al. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects. Clin Infect Dis 2005 Sep 15;41(6):815-21 [Full text]
Li T, Qiu Z, Zhang L, et al. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis 2004 Feb 15;189(4):648-51 [Abstract]
Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS-like coronavirus. Science 2005 Oct 28;310(5748):676 [Abstract]
Liang G, Chen Q, Xu J, et al. Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis 2004 Oct;10(10):1774-81 [Full text]
Liang W, Zhu Z, Guo J, et al. Severe acute respiratory syndrome, Beijing, 2003. Emerg Infect Dis 2004 Jan;10(1):25-31 [Full text]
Lim PL, Kurup A, Gopalakrishna G, et al. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 2004 Apr 22;350(17):1740-5 [Abstract]
Lingappa JR, McDonald LC, Simone P, et al. Wresting SARS from uncertainty. (Commentary) Emerg Infect Dis 2004 Feb;10(2) [Full text]
Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003 Jun 20;300(5627):1966-70 [Abstract]
Liu W, Fontanet A, Zhang PH. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis 2006 Mar 15;193(6):792-5 [Abstract]
Liu W, Tang F, Fontanet A, et al. Long-term SARS coronavirus excretion from patient cohort, China. Emerg Infect Dis 2004 Oct;10(10):1841-3 [Full text]
Liu W, Tang F, Fontanet A, et al. Molecular epidemiology of SARS-associated coronavirus, Beijing. Emerg Infect Dis 2005 Sep;11(9) [Full text]
Lo JYC, Tsang THF, Leung YH, et al. Respiratory infections during SARS outbreak, Hong Kong, 2003. Emerg Infect Dis 2005 Nov;11(11):1738-41 [Full text]
Loeb M, McGeerA, Henry B, et al. SARS among critical care nurses, Toronto. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Loeb MB. Severe acute respiratory syndrome: preparedness, management, and impact. (Editorial) Infect Control Hosp Epidemiol 2004 Dec;25(12) [Abstract]
Loon S-C, Teoh SCB, Oon LLE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 2004 Jul;88:861-3 [Abstract]
Louis JK, Hacker JK, Mark J, et al. SARS and common viral infections. Emerg Infect Dis 2004 Jun;10(6):1143-6 [Full text]
Loutfy MR, Wallington T, Rutledge T, et al. Hospital preparedness and SARS. (Perspective) Emerg Infect Dis 2004 May;10(5) [Full text]
Low DE, McGeer A. SARS: one year later. (Perspective) N Engl J Med 2003 Dec 18;349(25):2381-2 [Extract]
Low JGH, Lee CC, Leo YS, et al. Severe acute respiratory syndrome and pulmonary tuberculosis. Clin Infect Dis 2004 Jun 15;38(12):e123-5 [Abstract]
Lu L, Manopo I, Leung BP, et al. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004 Apr;42(4):1570-6 [Abstract]
Mahony JB, Petrich A, Louie L, et al. Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of SARS coronavirus. J Clin Microbiol 2004 Apr;42(4):1471-6 [Abstract]
Marra MA, Jones SJM, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003 May 30;300(5624):1399-404 [Abstract]
Martin JE, Louder MK, Holman LA, et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a phase I clinical trial. Vaccine 2008 Nov 25;26(50):6338-43 [Abstract]
Martina BE, Haagmans BL, Kuiken T, et al. Virology: SARS virus infection of cats and ferrets. Nature 2003 Oct 30;425:915 [PubMed listing with link to text]
Matsuyama S, Ujike M, Morikawa S, et al. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci 2005 (published online Aug 22) [Abstract]
Maunder RG, Lancee WJ, Balderson KE, et al. Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak. Emerg Infect Dis 2006 Dec;12(12) (published online Nov 14) [Full text]
Mazzulli T, Farcas GA, Poutanen SM, et al. Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004 Jan 10(1):20-4 [Full text]
McDonald LC, Simor AE, Su I-J, et al. SARS in healthcare facilities, Toronto and Taiwan. (Perspective) Emerg Infect Dis 2004 May;10(5) [Full text]
McGeer A. Let him who desires peace prepare for war: United States hospitals and severe acute respiratory syndrome preparedness. (Commentary) Clin Infect Dis 2004 Jul 15;39(2):275-7 [Full text]
Meltzer MI. Multiple contact dates and SARS incubation periods. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Misrahi JJ, Foster JA, Shaw FE, et al. HHS/CDC legal response to SARS outbreak. Emerg Infect Dis 2004 Feb;10(2) [Full text]
Moore D, Gamage B, Bryce E, et al. Protecting health care workers from SARS and other respiratory pathogens: Organizational and individual factors that affect adherence to infection control guidelines. Am J Infect Control 2005 Mar;22(2) [Abstract]
Muller MP, McGeer A, Straus SE, et al. Clinical trials and novel pathogens: lessons from SARS. Emerg Infect Dis 2004 Mar;10(3):389-94 [Full text]
Muller MP, Tomlinson G, Marrie TJ, et al. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clin Infect Dis 2005 Apr 15;40(8):1079-86 [Abstract]
Mullin S. New York City's communication trials by fire, from West Nile to SARS. Biosecurity Bioterrorism 2003;1(4):267-72
Nandi A, Tracy M, Aiello A, et al. Social support and response to AIDS and severe acute respiratory syndrome. Emerg Infect Dis 2008 May (published online Mar 28) [Full text]
National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004 Jul 22;351(4):327-36 [Abstract]
Ng MHL, Lau KM, Li L, et al. Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis 2004 Aug 1;190(3):515-8 [Abstract]
Ng ML, Lee JW, Leong ML, et al. Topographic changes in SARS coronavirus-infected cells at late stages of infection. Emerg Infect Dis 2004 Nov;10(11):1907-14 [Full text]
Ng SK. Possible role of an animal vector in the SARS outbreak at Amoy Gardens. Lancet 2003 Aug 16; 362(9383):570-2 [Abstract]
Nicholls JM, Butany J, Poon LL, et al. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med 2006 Feb;3(2) [Webpage]
Nicholls JM, Poon LM, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003 May 24;361(9371):1773-8 [Abstract]
Nie Y, Wang G, Shi X, et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis 2004 Sep 15;190(6):1119-26 [Abstract]
Nitsche A, Schweiger B, Ellerbrok H, et al. SARS coronavirus detection. Emerg Infect Dis 2004 Jul;10(7):1300-3 [ | 
